Loading...
NPI 1295785079 · Cottage Grove, WI · Mobile Radiology Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Shared Medical Services, Inc. is a mobile radiology clinic/center provider located in Cottage Grove, Wisconsin. This profile covers 3 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Shared Medical Services, Inc. |
| Address | 209 Limestone Pass |
| City | Cottage Grove |
| State | WI |
| ZIP | 53527 |
| Taxonomy | Mobile Radiology Clinic/Center |
| NPI Enumerated | May 11, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $825.5K |
| Medicaid | $628.5K |
Service-line profile: SHARED MEDICAL SERVICES, INC. operates as a Mobile Radiology Clinic/Center in Cottage Grove, WI, with billing concentrated in PET/CT imaging and the associated FDG radiopharmaceutical supply, as evidenced by heavy use of 78815, 78816, and A9552 across payers. The presence of both the imaging codes (78815, 78816) and the tracer code A9552 suggests an integrated mobile PET service that provides both scan acquisition and radionuclide dosing on-site.
Medicare revenue concentration: This provider's Medicare revenue is highly concentrated — the top 3 Medicare codes account for 100.0% of Medicare revenue, led by 78815 at $643.5K (77.9% of Medicare revenue), followed by A9552 at $143.6K (17.4%) and 78816 at $38.6K (4.7%). Such concentration indicates that virtually all Medicare reimbursement is driven by PET/CT imaging and its associated radiopharmaceutical dosing rather than a broader mix of imaging services.
Medicaid revenue concentration: Medicaid billing is similarly concentrated with the top 3 Medicaid codes accounting for 100.0% of Medicaid revenue; 78815 generates $526.8K (83.8% of Medicaid revenue) and A9552 generates $102.2K (16.2%). This pattern shows the provider’s Medicaid revenue is almost exclusively derived from PET/CT studies and FDG tracer administration within the state.
Payer mix and scale: SHARED MEDICAL SERVICES reports $825.5K in total Medicare revenue and $628.5K in total Medicaid revenue, so Medicare represents the larger single-payer source but Medicaid is also a substantial revenue stream. The organization is not effectively single-payer; both programs materially support its PET/CT-focused operations.
National competitive standing (Medicare): For Medicare activity the provider is a major national outlier on key PET metrics — 78815 ranks #164 of 6566 providers (98th percentile) and A9552 ranks #36 of 2411 providers (99th percentile, labeled an "extreme outlier"). By contrast, 78816 sits at #714 of 1983 providers (63th percentile, described as typical), signaling that the provider is nationally prominent for PET/CT volume and tracer dosing but unremarkable for ancillary PET/CT code activity.
State competitive standing (Medicaid): Within Wisconsin the provider ranks among the top in-state performers for PET/CT and tracer supply, with 78815 and A9552 both ranking #3 of 21 providers (90th percentile) for Medicaid. These positions indicate a strong regional presence in PET imaging services, occupying a top-tier slot among in-state competitors for these reimbursed services.
Tenure and operational continuity: The provider’s NPI was enumerated on 2006-05-11 (~20 years ago), indicating long-standing enrollment with federal payers and suggesting operational continuity of its mobile PET/CT service line over an extended period. This tenure supports interpretation of the observed high-volume PET billing as an established business focus rather than a short-term spike.
Statistical signal and interpretation: The billing profile contains a pronounced statistical signal where A9552 is documented as an "extreme outlier" nationally for Medicare while 78815 is "notably above typical national volume"; both codes are only "typical, unremarkable" in-state Medicaid rankings. This divergence implies exceptionally high national-level tracing/dose activity relative to national peers, while the provider’s in-state footprint is strong but more consistent with regional peers.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 570 | $1,120 | $643.5K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 610 | $240 | $143.6K |
| 78816 | The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The… | 40 | $1,100 | $38.6K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 3 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 1,060 | $500 | $526.8K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1,140 | $90 | $102.2K |
How this provider's Medicaid billing volume and revenue compare to other Wisconsin providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Wisconsin median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 3 | 20 | 160 | $200 | $102.5K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 3 | 20 | 80 | $10 | $5.2K |
Other providers in the same ZIP code as Shared Medical Services, Inc., ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Mabie Pharmacy, LLC | WI | Community/Retail Pharmacy | $293.1K | $22.9K |
| Deer-grove Ems District | WI | Land Ambulance | $143.5K | $37.9K |
| Joann Long | WI | Nurse Practitioner | $21.3K | $0 |
| Kathleen Knipfer | WI | Physician Assistant | $9.5K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.